Advertisement

Topics

NeuroMetrix Announces Issuance of New U.S. Patent for DPNCheck Point-of-Care Neuropathy Test Technology

11:32 EDT 6 Jul 2018 | Investing News Network

NeuroMetrix (Nasdaq:NURO) announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,004,445. The patent covers novel technology that enhances DPNCheck® device performance by detecting and rejecting erroneous test conditions during nerve conduction studies. As quoted in the press release: This patent further strengthens the position of the Company in offering easy-to-use, automated … Continued

The post NeuroMetrix Announces Issuance of New U.S. Patent for DPNCheck Point-of-Care Neuropathy Test Technology appeared first on Investing News Network.

Original Article: NeuroMetrix Announces Issuance of New U.S. Patent for DPNCheck Point-of-Care Neuropathy Test Technology

NEXT ARTICLE

More From BioPortfolio on "NeuroMetrix Announces Issuance of New U.S. Patent for DPNCheck Point-of-Care Neuropathy Test Technology"

Advertisement
Quick Search
Advertisement
Advertisement